COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic A/S – Notice Convening Ordinary General Meeting
28/03/2019
COPENHAGEN, Denmark, March 28, 2019 – Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the annual General Meeting to be held on Wednesday April 24 [...]
Santhera Provides Update on Filing for Conditional Marketing Authorization in Europe for Puldysa® (Idebenone) in Duchenne Muscular Dystrophy
28/03/2019
Pratteln, Switzerland, March 28, 2019 - Santhera Pharmaceuticals (SIX: SANN) announces its intention to file an application for Conditional Marketing Authorization (CMA) for Puldysa® (idebenone) for the treatment of [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
28/03/2019
Regulated information Gosselies, Belgium, 28 March 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
28/03/2019
Information réglementée Gosselies, Belgique, le 28 mars 2019, 07h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Supernus Hosts Conference Call to Present Topline Results of Final Phase III Study for SPN-812 in Adolescents with ADHD
27/03/2019
ROCKVILLE, Md., March 27, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Precision BioSciences Announces Pricing of Initial Public Offering
27/03/2019
DURHAM, N.C., March 27, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS genome editing platform, [...]
Genetically modified tequila bacterium produces cannabinoids from sugar: Farmako applies for a worldwide patent
27/03/2019
Standardized process for the production of cannabinoids First production of cannabinoids by biosynthesis without the use of yeast Production costs drop to one-thousandth of the previous costs FRANKFURT, Germany, March [...]
IntelGenx Grants Stock Options
27/03/2019
SAINT LAURENT, Quebec, March 27, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTC.QX:IGXT) announced today that the Company’s board of directors granted 100,000 [...]
Ascendis Pharma A/S Announces Year-End 2018 Financial Results and Business Update Conference Call on April 3
27/03/2019
COPENHAGEN, Denmark, March 27, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address unmet medical needs, today announced [...]
Trillium Therapeutics to Unveil its STING Agonist Program at the AACR Annual Meeting 2019
27/03/2019
TORONTO, March 27, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL), a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced it will be [...]
Heart of Home Care Event Celebrates Unpaid Caregivers on National Carers Day
27/03/2019
TORONTO, March 27, 2019 (GLOBE NEWSWIRE) -- VHA Home HealthCare, a not-for-profit, charitable organization, hosts its 15th annual Heart of Home Care Awards event on National Carers Day, Tuesday, April 2, honouring the [...]
Clarus Therapeutics Receives U.S. FDA Approval of JATENZO® (Testosterone Undecanoate Capsules for Oral Use) (CIII) for Testosterone Replacement Therapy in Certain Adult Men
27/03/2019
JATENZO is a first-in-class proprietary softgel oral formulation of testosterone undecanoate for testosterone replacement therapy in certain adult men, and the first oral testosterone medicine approved in more than 60 [...]
NeuroStar® Advanced Therapy to Receive Reimbursement Approval in Japan
27/03/2019
Proven, breakthrough non-drug treatment for depression provides safe and effective option to the country's critical public health issue MALVERN, Pa., March 27, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), [...]
Akari Therapeutics to Provide Update on its Eye Disease Program During Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
27/03/2019
Poster to be presented on back-of-the-eye program including data from uveitis preclinical model Interim data expected from Akari’s Phase I/II clinical trial in atopic keratoconjunctivitis (AKC), a surface of the eye [...]
California Legislature Seeks to Remove Private Physicians from Decisions on Medical Vaccine Exemptions, States Association of American Physicians and Surgeons (AAPS)
27/03/2019
TUCSON, Ariz., March 27, 2019 (GLOBE NEWSWIRE) -- California has already done away with religious and philosophical exemptions from mandated childhood vaccines , reports the Association of American Physicians and [...]
Equillium Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
27/03/2019
Initiated the EQUATE Phase 1b/2 trial in acute graft-versus-host disease in March 2019 LA JOLLA, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep [...]
electroCore Announces Fourth Quarter and Full Year 2018 Financial Results
27/03/2019
Fourth quarter 2018 prescription growth of more than 30% from third quarter 2018 Company to host conference call and webcast today, March 27, at 4:30pm ET BASKING RIDGE, N.J., March 27, 2019 (GLOBE NEWSWIRE) -- [...]
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
27/03/2019
– Conference Call Scheduled March 27, 2019 at 4:30 p.m. EDT – BERKELEY HEIGHTS, N.J., March 27, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") a [...]
HTG Introduces the HTG EdgeSeq Mouse mRNA Tumor Response Panel
27/03/2019
TUCSON, Ariz., March 27, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has released a new HTG [...]

Pages